secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2023-01-19T23:59:59+00:00
Accession:  0000898432-23-000021
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRadimed reports preliminary Q4 revenue $14.9M (+25% YoY); issues FY2023 guidance $61M-$63M
--------------------------------------------------------------------------------

- Q4 2022 preliminary revenue $14.9M, up 25% YoY, above guidance of $14.1M-$14.8M.
- Sixth consecutive quarterly revenue record; orders exceeded shipments, increasing backlog.
- FY2023 guidance: revenue $61M-$63M, GAAP EPS $1.10-$1.20, non-GAAP EPS $1.23-$1.34.
- Q1 2023 guidance: revenue $14.6M-$14.9M, GAAP EPS $0.23-$0.25, non-GAAP EPS $0.26-$0.28.
- Full year 2022 revenue grew 27.5% over 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/0000898432-23-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-23-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer